Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Lactobacilli Supplements for Implantation Failure
NCT03843112Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- Mar 2019
- Primary completion
- Jan 2021
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of EcoVag in bacterial vaginosis (BV), implantation failure, sponsored by Zealand University Hospital. Started Mar 2019; status: completed.
02
Drugs
EcoVag
03
Conditions
bacterial vaginosis (BV)implantation failure
Beyond the preview
Go deeper on NCT03843112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03843112.